R. David Hoover, Director at Elanco Animal Health Inc (ELAN), bought 5,000 shares at $31.79 ($159K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market purchase of $159k ELAN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ELAN | BUY | 2023-03-15 | $95K | — | Filing → |
| ELAN | BUY | 2023-03-07 | $223K | — | Filing → |
| ELAN | BUY | 2022-09-09 | $304K | — | Filing → |